Those risks include an increased risk of birth defects, including persistent pulmonary hypertension of the newborn (PPHN), cardiac defects, abnormally shaped skull, club foot and defects of the brain and spinal cord, in babies exposed to Effexor prior to birth. Furthermore, babies exposed to Effexor before birth could be at an increased risk of developmental delays, including sitting up later and having more difficulty occupying themselves than babies not exposed to SSRIs or Effexor.
Although much research has been done on selective serotonin reuptake inhibitors (SSRIs), Effexor, which is a serotonin-norepinephrine reuptake inhibitor (SNRI), is often included in the research because it is similar to SSRIs. The main difference is that Effexor affects levels of both serotonin and norepinephrine, while SSRIs affect only levels of serotonin.
READ MORE EFFEXOR BIRTH DEFECTS LEGAL NEWS
Specifically, women who took Effexor had double the risk of miscarriage prior to the 20th week of pregnancy. The study does not prove that taking an antidepressant while pregnant causes the miscarriage, simply that there is a link between taking the antidepressant and a risk of miscarriage.
There is also a risk to the unborn fetus when the mother has untreated depression. This means that women who are depressed and are pregnant or thinking about becoming pregnant should carefully weigh the risks and benefits of taking Effexor while pregnant. Those who are pregnant and concerned about their Effexor use should not discontinue medication without speaking to a medical professional.